Critical considerations on the combined use of 18F-FDG and 18F-fluoride for PET assessment of metastatic bone disease

G. Cheng; T.C. Kwee; S. Basu; A. Alavi

doi:10.1007/s00259-013-2459-y

Critical considerations on the combined use of 18F-FDG and 18F-fluoride for PET assessment of metastatic bone disease

Translated title of the contribution: Critical considerations on the combined use of 18F-FDG and 18F-fluoride for PET assessment of metastatic bone disease

G. Cheng
, T.C. Kwee
, S. Basu
, A. Alavi

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Critical considerations on the combined use of 18F-FDG and 18F-fluoride for PET assessment of metastatic bone disease
Original language	Undefined/Unknown
Pages (from-to)	1141-1145
Number of pages	5
Journal	European Journal of Nuclear Medicine and Molecular Imaging
Volume	40
Issue number	8
DOIs	https://doi.org/10.1007/s00259-013-2459-y
Publication status	Published - 2013

Access to Document

10.1007/s00259-013-2459-y

http://www.ncbi.nlm.nih.gov/pubmed/23695838

Cite this

@article{b40ec1f4284b4f178132c1f765865c61,

title = "Critical considerations on the combined use of 18F-FDG and 18F-fluoride for PET assessment of metastatic bone disease",

author = "G. Cheng and T.C. Kwee and S. Basu and A. Alavi",

year = "2013",

doi = "10.1007/s00259-013-2459-y",

language = "Undefined/Unknown",

volume = "40",

pages = "1141--1145",

journal = "European Journal of Nuclear Medicine and Molecular Imaging",

issn = "1619-7070",

publisher = "Springer",

number = "8",

}

TY - JOUR

T1 - Critical considerations on the combined use of 18F-FDG and 18F-fluoride for PET assessment of metastatic bone disease

AU - Cheng, G.

AU - Kwee, T.C.

AU - Basu, S.

AU - Alavi, A.

PY - 2013

Y1 - 2013

U2 - 10.1007/s00259-013-2459-y

DO - 10.1007/s00259-013-2459-y

M3 - Article

C2 - 23695838

SN - 1619-7070

VL - 40

SP - 1141

EP - 1145

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

IS - 8

ER -